160889-18-9

Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate is used in the preparation of phenylpyrazinoylguanidines as sodium channel blockers possessing β-agonist activity. These compounds are useful for promoting hydration of mucosal surfaces and treating a variety of disease conditions.